Trualt Bioenergy (NSE:TRUALT) Notes Receivable: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TRUALT Trualt Bioenergy Ltd NSE:TRUALT
42 GF Score
Price ₹420.65
! 7 Warning Signs
View Full Analysis

What is Trualt Bioenergy Notes Receivable?

Trualt Bioenergy NSE:TRUALT -1.67% 42 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:TRUALT with a GF Score™ of 42/100. The stock has 7 warning signs investors should review.

Trualt Bioenergy's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Trualt Bioenergy Notes Receivable Related Terms

Trualt Bioenergy Notes Receivable Historical Data

* Premium members only.

The historical data trend for Trualt Bioenergy's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trualt Bioenergy Notes Receivable Chart

Trualt Bioenergy Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Trualt Bioenergy Quarterly Data
Mar21 Mar22 Sep22 Mar23 Mar24 Dec24 Mar25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:TRUALT
42GF Score
Trualt Bioenergy Ltd NSE:TRUALT
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trualt Bioenergy Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Trualt Bioenergy (NSE:TRUALT) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Trualt Bioenergy and its competitors.
Is Trualt Bioenergy's Notes Receivable too high?
Trualt Bioenergy's current Notes Receivable is ₹0 Mil. Overall, Trualt Bioenergy has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Trualt Bioenergy's Notes Receivable compare to VLO and MPC?
Trualt Bioenergy's Notes Receivable of ₹0 Mil can be compared against companies in the Oil & Gas industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Oil & Gas company?
A good Notes Receivable depends on the Oil & Gas industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Trualt Bioenergy and its competitors. Trualt Bioenergy's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trualt Bioenergy stock overvalued right now?
Trualt Bioenergy (NSE:TRUALT) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Trualt Bioenergy's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Trualt Bioenergy (NSE:TRUALT), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trualt Bioenergy Business Description

Industry EnergyOil & Gas
Other Exchanges 544545:India
Address No. 26/1, Dr. Rajkumar Road, No S-904/A, 9th Floor, World Trade Center, Brigade Gateway Campus, Bangalore, KA, IND, 560055
Trualt Bioenergy Ltd is a biofuels producer, particularly in the Ethanol sector. As part of its Ethanol production, the company also produces extra neutral alcohol (ENA), the raw material in the production of alcoholic beverages. Its product portfolio also includes dry ice and liquid carbon dioxide (CO2), by-products in the Ethanol production process. The group is engaged in the business of manufacturing, selling ethanol and compressed biogas, and other products derived from distillery processes.
42GF Score

Get the complete analysis for NSE:TRUALT

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹420.65
Price